πŸ‡ΊπŸ‡Έ FDA

Intelligence Platform

Patents

Browse 115 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 8440707

Antagonists of lysophosphatidic acid receptors

AMIRA PHARMACEUTICALS, INC. Β· Granted Tue May 14 2013 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 09 2033 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8273780

Polycyclic antagonists of lysophosphatidic acid receptors

AMIRA PHARMACEUTICALS, INC. Β· Granted Tue Sep 25 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 20 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8217066

Compounds as lysophosphatidic acid receptor antagonists

AMIRA PHARMACEUTICALS, INC. Β· Granted Tue Jul 10 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 05 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8182835

Sustained-release liposomal anesthetic compositions

Pacira Pharmaceuticals, Inc. Β· Granted Tue May 22 2012 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 17 2032 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8058300

Polycyclic antagonists of lysophosphatidic acid receptors

AMIRA PHARMACEUTICALS, INC. Β· Granted Tue Nov 15 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 10 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 8048902

Antagonists of lysophosphatidic acid receptors

AMIRA PHARMACEUTICALS, INC. Β· Granted Tue Nov 01 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 27 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7977359

5-lipdxygenase-activating protein (FLAP) inhibitors

AMIRA PHARMACEUTICALS, INC. Β· Granted Tue Jul 12 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 07 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7919621

Tricyclic inhibitors of 5-lipoxygenase

AMIRA PHARMACEUTICALS, INC. Β· Granted Tue Apr 05 2011 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 31 2031 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7834037

5-lipoxygenase-activating protein (FLAP) inhibitors

AMIRA PHARMACEUTICALS, INC. Β· Granted Tue Nov 16 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Nov 11 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7795274

5-lipoxygenase-activating protein (FLAP) inhibitors

AMIRA PHARMACEUTICALS, INC. Β· Granted Tue Sep 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7405302

5-lipoxygenase-activating protein (FLAP) inhibitors

AMIRA PHARMACEUTICALS, INC. Β· Granted Tue Jul 29 2008 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jul 24 2028 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7309702

Arylpiperazines having activity at the serotonin 1A receptor

Avera Pharmaceuticals, Inc. Β· Granted Tue Dec 18 2007 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Dec 13 2027 00:00:00 GMT+0000 (Coordinated Universal Time)

granted
patent

US 7001908

Arylpiperazines having activity at the serotonin 1A receptor

Avera Pharmaceuticals, Inc. Β· Granted Tue Feb 21 2006 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Feb 16 2026 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6395311

Multicomponent biological vehicle

Univera Pharmaceuticals, Inc. Β· Granted Tue May 28 2002 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon May 23 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6271214

Process for the preparation of immunomodulatory polysaccharides from aloe

Univera Pharmaceuticals, Inc. Β· Granted Tue Aug 07 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Aug 02 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6210680

Method for the prevention and treatment of chronic venous insufficiency

Univera Pharmaceuticals, Inc. Β· Granted Tue Apr 03 2001 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Mar 29 2021 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6133440

Process for the preparation of immunomodulatory polysaccharides from aloe

Univera Pharmaceuticals, Inc. Β· Granted Tue Oct 17 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Oct 12 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6123959

Aqueous composition comprising active ingredients for the de-pigmentation of the skin

Univera Pharmaceuticals, Inc. Β· Granted Tue Sep 26 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Sep 21 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired
patent

US 6083976

Method of synthesis of derivatives of aloesin

Univera Pharmaceuticals, Inc. Β· Granted Tue Jul 04 2000 00:00:00 GMT+0000 (Coordinated Universal Time) Β· Expires Mon Jun 29 2020 00:00:00 GMT+0000 (Coordinated Universal Time)

expired